Similar documents
Chronic Kidney Disease

QUICK REFERENCE FOR HEALTHCARE PROVIDERS

Prevention And Treatment of Diabetic Nephropathy. MOH Clinical Practice Guidelines 3/2006 Dr Stephen Chew Tec Huan

TREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009

Kidney Disease, Hypertension and Cardiovascular Risk

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

CKDinform: A PCP s Guide to CKD Detection and Delaying Progression

Irish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012

Renal Protection Staying on Target

Management of New-Onset Proteinuria in the Ambulatory Care Setting. Akinlolu Ojo, MD, PhD, MBA

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives

E.Ritz Heidelberg (Germany)

Case Studies: Renal and Urologic Impairments Workshop

CKD FOR INTERNISTS. Dr Ahmed Hossain Associate professor Medicine Sir Salimullah Medical College

Update on HIV-Related Kidney Diseases. Agenda

Diabetes and Hypertension

Chronic kidney disease-what can you do and when to refer?

Metabolic Syndrome and Chronic Kidney Disease

Stages of Chronic Kidney Disease (CKD)

Hypertension and diabetic nephropathy

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

Outline. Outline. Introduction CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 8/11/2011

ACE Inhibitors and Protection Against Kidney Disease Progression in Patients With Type 2 Diabetes: What s the Evidence?

Outline. Introduction. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 6/26/2012

Chronic Kidney Disease Management for Primary Care Physicians. Dr. Allen Liu Consultant Nephrologist KTPH 21 November 2015

The hypertensive kidney and its Management

Difficult to Treat Hypertension

ACEIs / ARBs NDHP dihydropyridine ( DHP ) ACEIs ARBs ACEIs ARBs NDHP. ( GFR ) 60 ml/min/1.73m ( chronic kidney disease, CKD )

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

Supplementary Appendix

Diabetes in Renal Patients. Contents. Understanding Diabetic Nephropathy

Guest Speaker Evaluations Viewer Call-In Thanks to our Sponsors: Phone: Fax: Public Health Live T 2 B 2

Diabetic Nephropathy Larry Lehrner, Ph.D.,M.D.

Diabetic Nephropathy 2009

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria

Outline. Outline 10/14/2014 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?

Management of Hypertensive Chronic Kidney Disease: Role of Calcium Channel Blockers. Robert D. Toto, MD

The CARI Guidelines Caring for Australians with Renal Impairment. Specific effects of calcium channel blockers in diabetic nephropathy GUIDELINES

RENAAL, IRMA-2 and IDNT. Three featured trials linking a disease spectrum IDNT RENAAL. Death IRMA 2

Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin

Reducing proteinuria

VA/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care (2008) PROVIDER REFERENCE CARDS Chronic Kidney Disease

Kidney Disease. Chronic kidney disease (CKD) requiring dialysis. The F.P. s Role in the Management of Chronic. Stages

Special Challenges and Co-Morbidities

Quality ID #119 (NQF 0062): Diabetes: Medical Attention for Nephropathy National Quality Strategy Domain: Effective Clinical Care

SLOWING PROGRESSION OF KIDNEY DISEASE. Mark Rosenberg MD University of Minnesota

Characteristics of factor x so that its clearance = GFR. Such factors that meet these criteria. Renal Tests. Renal Tests

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine

University of Groningen. Evaluation of renal end points in nephrology trials Weldegiorgis, Misghina Tekeste

Diabetes and kidney disease.

Cardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center

Chronic Kidney Disease for the Primary Care Physician in What do the Kidneys do? CKD in the US

Kerry Cooper M.D. Arizona Kidney Disease and Hypertension Center April 30, 2009

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD

Effective Health Care Program

Introduction to Clinical Diagnosis Nephrology

Identifying and Managing Chronic Kidney Disease: A Practical Approach

RETARDING PROGRESSION OF CHRONIC KIDNEY DISEASE (CKD)

Diabetic Nephropathy

Dr Doris M. W Kinuthia

CKD IN THE CLINIC. Session Content. Recommendations for commonly used medications in CKD. CKD screening and referral

Diabetes has become the most common

Aggressive blood pressure reduction and renin angiotensin system blockade in chronic kidney disease: time for re-evaluation?

Chronic Kidney Disease. Basics of CKD Terms Diagnosis Management

Keywords albuminuria, hypertension, nephropathy, proteinuria

Primary Care Approach to Management of CKD

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC

Diabetic Kidney Disease: Update. GKA Master Class. Istanbul 2011

Tread Carefully Because you Tread on my Nephrons. Prescribing Hints in Renal Disease

The CARI Guidelines Caring for Australasians with Renal Impairment. ACE Inhibitor and Angiotensin II Antagonist Combination Treatment GUIDELINES

Management of Early Kidney Disease: What to do Before Referring to the Nephrologist

Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin

Transforming Diabetes Care

Lessons learned from AASK (African-American Study of Kidney Disease and Hypertension)

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults

6/10/2014. Chronic Kidney Disease - General management and standard of care. Management of CKD according to stage (KDOQI 2002)

Outpatient Management of Chronic Kidney Disease for the Internist

ALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)

A New Approach for Evaluating Renal Function and Predicting Risk. William McClellan, MD, MPH Emory University Atlanta

Office Management of Reduced GFR Practical advice for the management of CKD

Diabetes and Kidney Disease. Kris Bentley Renal Nurse practitioner 2018

Supplementary Online Content

Diabetic Kidney Disease in the Primary Care Clinic

Morbidity & Mortality from Chronic Kidney Disease

Classification of CKD by Diagnosis

신장환자의혈압조절 나기영. Factors involved in the regulation of blood pressure

ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN TYPE I DIABETIC NEPHROPATHY DR.NASIM MUSA

egfr > 50 (n = 13,916)

Hypertension in Geriatrics. Dr. Allen Liu Consultant Nephrologist 10 September 2016

CLINICIAN INTERVIEW A REVIEW OF THE CURRENT TREATMENT MODALITIES FOR DIABETIC NEPHROPATHY. Interview with Ralph Rabkin, MD

Analytical Methods: the Kidney Early Evaluation Program (KEEP) The Kidney Early Evaluation program (KEEP) is a free, community based health

S150 KEEP Analytical Methods. American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 2010:pp S150-S153

(renoprotective (end-stage renal disease, ESRD) therapies) (JAMA)

HYPERTENSION GUIDELINES WHERE ARE WE IN 2014

Protecting the kidneys in lupus nephritis

Diabetes has become the most common

CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

The CARI Guidelines Caring for Australasians with Renal Impairment. Protein Restriction to prevent the progression of diabetic nephropathy GUIDELINES

Transcription:

www.usrds.org www.usrds.org 1

1,749 + (2,032) 1,563 to <1,749 1,414 to <1,563 1,283 to <1,414 Below 1,283 (1,178) December 31 point prevalent ESRD patients. By HSA; rates adjusted for age, gender, and race. Excludes patients residing in Puerto Rico and the Territories. Number of Patients (in thousands) 300 250 200 150 100 50 Incidence Other Diabetes 0 1980 1990 2000 2010 2020 2030 1,500 Prevalence 1,250 1,000 750 500 250 Other Diabetes 0 1980 1990 2000 2010 2020 2030 www.usrds.org. Diabetes mellitus Hypertension Glomerulonephritis IgA nephropathy Minimal change/membranous/fsgs 2

About 15% of the U.S. population has CKD Most CKD patients die of heart disease before reaching ESRD About 547,000 patients on dialysis or with a kidney transplant About 382,000 dialysis; 165,000 transplant Death rates are 20% per year for dialysis population and the number of end-stage patients rises about 1 3% each year Medicare spent 26.8 billion dollars in 2008, which is 5.9% of the Medicare budget www.usrds.org Glomerular filtration rate Albuminuria/proteinuria (140 age) Weight (kg) X X 0.85 (if female) Serum Cr 72 3

Many doctors might think her GFR is about 60 70 ml/min (140 70) 55 X 1.5 72 X 0.85 (for a female) = 30.3 ml/min Estimated GFR (ml/min/1.73m 2 ) = 186 x (scr) 1.154 x (Age) 0.203 x (0.742 if female) x (1.210 if African American) = exp(5.228 1.154xln(SCr) 0.203 x In(Age) (0.299 if female) + (0.192 if African American) Cockcroft-Gault Formula Creatinine Clearance Estimated Clearance = (140 age/serum Cr) x wt (kg)/72 x (0.85 if female) Complications of renal disease (e.g., anemia, renal osteodystrophy, malnutrition, and volume regulatory disorders) are seen with increasing frequency at Stage 3 kidney disease (GFR <60 ml/min) Deleterious relationship between chronic kidney disease and cardiovascular disease Risk for contrast dye nephropathy Drug dose adjustments 4

Poor correlation to actual GFR when GFR is greater than 60 ml/min Not accurate for acute renal failure Nor is any GFR estimate CKD-EPI formula appears to be more accurate for GFR >60 ml/min Normal renal excretion is about 200 300 mg/day of total protein (up to 20 mg is albumin) Single specimen urine albumin/creatinine ratio Normal <30 mg/g Microalbuminuria 30 300 mg/g Macroalbuminuria >300 mg/g Schwab SJ et al. Arch Int Med. 1987;83:405-410. 5

6 5 4 Relative Risk 3 of IHD 2 General Population Normoalbuminuria Microalbuminuria 1 0 10-y follow-up, n = 2085 Female Male Borch-Johnsen K et al. Arterioscler Thromb Vasc Biol. 1999;19:1992-1997. Ninomiya T et al. J Am Soc Nephrol. 2009;20:1813-1819. 6

A1C of <7% Blood pressure control <130/80 mm Hg Lower urine albumin level Dietary interventions as indicated Low salt intake for hypertension control No role for low-protein diet Stop smoking Writing Team for the DCCT. JAMA. 2003;290:2159-2167. 7

Pickering TG et al. Hypertension. 2008;52:1-9 Primary hyperaldosteronism Renal artery stenosis 8

Umpierrez GE et al. Diabetes Care. 2007;30:1699-1703. Diagnose angiography with contrast dye Angiography with radiocontrast dye Magnetic resonance angiography with gadolinium Duplex ultrasound Dye is potentially toxic to the kidney Prehydration with IV 1/2 normal saline lowers incidence of acute renal failure Surgical intervention usually does not improve outcomes compared with medical management 9

ASTRAL Investigators. N Engl J Med. 2009;361:1953-1962. <130/80 mm Hg 10

NKF-KDOQI Guidelines. Intensive BP 118/75 Moderate BP 124/80 Estacio RO et al. Am J Hypertens. 2006;19:1241-1248. 11

BP = Cardiac Output x Total Peripheral Resistance Heart Rate x Stroke Volume blockers Salt Restriction Diuretics (e.g., thiazides) Natriuretics (e.g., ANP, BNP) Aquaretics (AVP Rec. Antagonist) Aldosterone Antagonist Calcium Channel Blockers Dihydropyridines Nondihydropyridines Angiotensin II Inhibitors Renin Inhibitor Central Adrenergic Agonists Alpha Blockers Nitric Oxide Enhancers It doesn t matter Because 3 or more drugs are usually needed Target other associated diseases Recent myocardial infarction Congestive heart failure Kidney disease Although an ACE inhibitor is a reasonable first choice, as there is evidence of activated RAAS in diabetes 12

Mauer MM et al. N Engl J Med. 2009,;61:40-51. ACE inhibitors and/or angiotensin receptor blockers should be administered to patients with increased urine albumin/protein even with normal blood pressure Placebo Captopril Lewis EJ et al. N Engl J Med. 1993;329:1456-1462. 13

coe.fgcu.edu/.../greenep/kidney/glomerulus.html. Holtkamp FA et al. Kidney Int. 2011;80:282-287. Jennings DL et al. Diabet Med. 2007;24:486-493. 14

ONTARGET Investigators. N Engl J Med. 2008;358:1547-1549. Current evidence: All patients with increased urine albumin (or total protein) should be on an ACE inhibitor or angiotensin receptor blocker, even if the patient has excellent blood pressure Avoid combination of ACE-I and ARB in patients with normal kidney function and no increase in urine albumin/protein level Use combination in patients with kidney disease to decrease high urine albumin/proteinuria levels 15

Postgraduate Med. 2009. Parving HH et al. N Engl J Med. 2008;358:2433-2446. Postgraduate Med. 2009. 16

Schrier RW et al. Clin J Amer Soc Nephrol. 2010;5:1132-1140. Mehdi UF et al. J Amer Soc Nephrol. 2009;20:26412650. 17

DCA NDCA Bakris GL et al. Kidney Int. 2004;65:1991-2002. McCormick BB et al. Am J Kidney Dis. 2008;52:454-463. Difficult-to-control hypertension Hypertension management questions Questions about managing RAAS inhibitors Questions about treatment of albuminuria Worsening renal function Unexplained urinalysis findings (e.g., proteinuria, hematuria) Questions about diagnosis Questions about diagnosis or management of disorders of electrolytes, acid-base, calcium/phosphate, and anemia, especially in patients with chronic kidney disease 18

Measure serum creatinine and use MDRD or CKD-EPI formula to estimate GFR Measure urine albumin/creatinine ratio in spot urine specimen Cardiac evaluation as indicated A1C <7% Blood pressure control <130/80 mm Hg Lower urine albumin level RAAS blockade/blood glucose control/hypertension control Dietary interventions as indicated Low salt intake for hypertension control No role for low-protein diet Stop smoking 19